Hamilton Hospitals Pioneer New Stroke Prevention Procedure
- Hamilton Health Sciences (HHS) has become the first hospital site in North America and most of the world to perform a new procedure using tiny filters to prevent...
- The procedure involves the placement of Vine carotid filters into the carotid arteries on each side of the neck.
- The implementation of these filters is part of a global Phase 3 clinical trial.
Hamilton Health Sciences (HHS) has become the first hospital site in North America and most of the world to perform a new procedure using tiny filters to prevent strokes.
The procedure involves the placement of Vine carotid filters into the carotid arteries on each side of the neck. These filters are designed to trap blood clots, preventing them from traveling to the brain and causing a stroke.
Phase 3 Clinical Trial
The implementation of these filters is part of a global Phase 3 clinical trial. This study is being conducted through a partnership between a medical device company and the stroke and neuro-intervention teams at Hamilton General Hospital.

Researchers are investigating whether the addition of these filters to standard blood thinner treatments can reduce the number of strokes caused by large vessel blockages inside the brain. The trial is also evaluating the safety of the filters and their ability to improve overall patient outcomes.
Procedure and Early Results
Early results indicate that the procedure is minimally invasive and can be performed as a same-day treatment. The findings are described as quick, safe, and promising
in the context of stroke prevention innovation.
Clinical trials are used to evaluate promising new treatments that are not yet in regular medical use. Such trials can provide an alternative option for patients when standard treatments are not the best choice or are not working effectively.
